Femtech 市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Femtech Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月03日 | 出版商:

Global Market Insights Inc. | 英文 131 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球女性科技市場價值為 551 億美元，預計 2024 年至 2032 年將以 12.8% 的年複合成長率(CAGR) 擴大。上升推動的。癌症、糖尿病、高血壓和精神健康障礙等慢性疾病以及愛滋病毒和結核病等傳染病的顯著增加對女性人口產生了重大影響。這種日益增加的負擔凸顯了迫切需要針對這些緊迫的健康問題量身定做有效的醫療保健解決方案。女性科技市場分為產品、軟體和服務。

2023 年，軟體領域成為領先者，創造了 2,850 萬美元的收入。人們對女性健康的日益認知，特別是在以前被忽視的領域，如月經和生殖健康，是這一領域成長的主要推動力。每個月都有月經週期的大量育齡婦女進一步強調了該市場的創新和發展潛力。從應用來看，女性科技市場涵蓋生殖健康、懷孕保健、孕產婦/產後及護理、身心綜合健康、整體福祉等領域。

2023 年，生殖健康領域佔據主導地位，佔 43.8% 的市場。在教育措施和社會運動的推動下，人們對女性獨特的健康挑戰（包括生育、月經、懷孕和更年期）的認知大幅提高。這種意識的提高培養了更知情的消費者群體，渴望獲得專門的生殖健康解決方案。 2023 年，北美女性科技市場收入為178 億美元，預計2024 年至2032 年複合年成長率為13%。。許多女性表示，由於成本問題而推遲或放棄醫療保健，這表明市場對更容易獲得的解決方案的巨大需求。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	551 億美元
預測值	1,359 億美元
複合年成長率	12.8%

產業生態系統分析
產業影響力
- 成長動力
  - 已開發國家利用數位科技管理女性健康
  - 改善偏遠地區婦女獲得照護的機會
  - 發展中國家對婦女健康和保健的認知不斷提高
  - 女性人口中慢性病和傳染病的負擔日益增加
  - 女性科技業投資不斷增加
- 產業陷阱與挑戰
  - 對女性科技產品與應用缺乏認知
成長潛力分析
監管環境
- 美國
- 歐洲
- 亞太地區
技術景觀
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
產品
軟體
服務

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
生殖健康
- 月經週期和生育能力
  - 避孕
  - 妊娠檢測
  - 生育力測試和受孕支持
  - 循環監控
  - 生殖健康指導
- 停經
孕期護理
- 懷孕進展洞察應用程式
- 懷孕交流網路及家長教育
- 孕期健康指導
- 墮胎和流產支持
產婦/產後及護理
- 產後支持
- 母乳哺育與哺乳支持
- 個人發展
身心健康及整體福祉
- 疼痛緩解和管理
- 懷孕健康監測
- 父母健康
- 疾病預防與檢測
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
直接面對消費者
醫院
生育診所
手術中心
診斷中心
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 俄羅斯
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 9 章：公司簡介

Amazon.com, Inc.
AVA Women
Clue (BioWink GmbH)
Conceivable
Daysy (Valley Electronics AG)
Elvie (Chiaro Technology Ltd.)
Flo Health Inc.
Google Nest (Alphabet Inc.)
HeraMED Limited
LactApp Women's Health SL
LunaJoy
MASIMO CORPORATION
Maven Clinic
Nanit
Natural Cycles
Peppy Health Limited
Preglife
Pregnancy+ (Koninklijke Philips NV)
Soula - AI (Mamatech Ltd.)
Univfy Inc.

簡介目錄

Product Code: 4442

The Global Femtech Market was valued at USD 55.1 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2032. This growth is primarily fueled by the increasing prevalence of chronic and infectious diseases affecting women. A notable rise in chronic health conditions such as cancer, diabetes, hypertension, and mental health disorders, along with infectious diseases like HIV and tuberculosis, has had a significant impact on the female population. This growing burden highlights the urgent need for effective healthcare solutions tailored to address these pressing health issues. The femtech market is categorized into products, software, and services.

In 2023, the software segment emerged as the leader, generating USD 28.5 million in revenue. The growing recognition of women's health, particularly in previously overlooked areas such as menstrual and reproductive health, is a major driver of growth in this segment. The substantial number of women of reproductive age experiencing menstrual cycles each month further emphasizes the potential for innovation and development within this market. In terms of application, the femtech market encompasses reproductive health, pregnancy care, maternal/postpartum and nursing care, integrative physical and mental health, and overall well-being.

The reproductive health segment dominated in 2023, capturing 43.8% of the market share. Increased awareness surrounding women's unique health challenges-including fertility, menstruation, pregnancy, and menopause-has surged, largely driven by educational initiatives and social movements. This heightened awareness has cultivated a more informed consumer base eager to access specialized reproductive health solutions. North America accounted for USD 17.8 billion in femtech market revenue in 2023, with a projected growth rate of 13% CAGR from 2024 to 2032. This growth is driven by rising awareness of women's health issues and the benefits of femtech innovations.Women are continuously seeking individualized, available, and effective healthcare alternatives. Many women have reported delaying or forgoing healthcare due to cost concerns, indicating a significant demand for more accessible solutions in the market.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$55.1 Billion
Forecast Value	$135.9 Billion
CAGR	12.8%

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Usage of digital technology to manage women health in developed countries
  - 3.2.1.2 Improving access to women care in remote areas
  - 3.2.1.3 Growing awareness regarding women health and wellness in developing countries
  - 3.2.1.4 Increasing burden of chronic and infectious diseases among the female population
  - 3.2.1.5 Growing investments in femtech industry
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of awareness about femtech products and applications
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.4.3 Asia Pacific
3.5 Technological landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Product
5.3 Software
5.4 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Reproductive health
- 6.2.1 Menstrual cycle & fertility
  - 6.2.1.1 Contraception
  - 6.2.1.2 Pregnancy testing
  - 6.2.1.3 Fertility testing & conception support
  - 6.2.1.4 Cycle monitoring
  - 6.2.1.5 Reproductive health guidance
- 6.2.2 Menopause
6.3 Pregnancy care
- 6.3.1 Pregnancy progress insights apps
- 6.3.2 Pregnancy exchange network & parental education
- 6.3.3 Pregnancy health guidance
- 6.3.4 Abortion & miscarriage support
6.4 Maternal/postpartum and nursing care
- 6.4.1 Postpartum support
- 6.4.2 Breastfeeding & lactation support
- 6.4.3 Personal development
6.5 Integrative physical and mental health & overall well-being
- 6.5.1 Pain relief and management
- 6.5.2 Pregnancy health monitoring
- 6.5.3 Parental health
- 6.5.4 Disease prevention and detection
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Direct-to-consumer
7.3 Hospitals
7.4 Fertility clinics
7.5 Surgical centers
7.6 Diagnostic centers
7.7 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Russia
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa